The MATCH Study: Mindfulness And Tai Chi for Cancer Health
Launched by LINDA E. CARLSON · Jun 10, 2016
Trial Information
Current as of August 11, 2025
Unknown status
Keywords
ClinConnect Summary
Background While there is ample research documenting the problems people diagnosed with cancer face, including high levels of distress, anxiety, depression and symptoms such as fatigue, pain and sleep disturbance, there is also a limited but growing body of evidence supporting the efficacy of a range of mind-body therapies (MBTs) in alleviating these and other symptoms. The investigators have chosen to focus on comparing MBCR and TCQ because both have level 1 evidence in cancer care, and both have shown potential to affect important biomarkers and clinical outcomes. Both interventions are s...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Men and women over the age of 18
- • 2. Diagnosed with any type of cancer (stage I-III) excluding head, neck, or brain
- • 3. Completed active treatment (i.e. surgery, chemotherapy, radiation therapy) at least 4 months previously (ongoing hormonal therapies, AIs, tamoxifen, herceptin are not exclusionary)
- • 4. Experiencing significant distress (4 or greater on the Distress Thermometer)
- • 5. Able to attend MBCR or TCQ classes at scheduled times
- • 6. Sufficient functional capacity to participate in intervention groups (as judged by PAR-Q questionnaire, study staff, participant and participant's physician)
- • 7. Ability to speak and write English sufficiently to complete questionnaires and participate in groups.
- Exclusion Criteria:
- • 1. Metastatic patients and those with ongoing chemotherapy (because ongoing therapy may impair biomarker profiles, and metastatic patients may not be stable enough to participate in the interventions and follow-up assessments).
- • 2. Cognitive impairment that would interfere with completing questionnaires or the intervention.
- • 3. Suffering from current Major Depressive Disorder, Bipolar Disorder or other psychiatric disorder that would interfere with the ability to participate.
- • 4. Currently engages in meditation or tai chi one or more times per week
- • 5. Previous participation in MBCR program.
About Linda E. Carlson
Linda E. Carlson is a distinguished clinical trial sponsor renowned for her commitment to advancing healthcare research through innovative clinical studies. With a focus on exploring integrative approaches to cancer care and psycho-oncology, she leads initiatives that bridge the gap between psychological well-being and physical health outcomes. Her expertise in designing and managing clinical trials ensures rigorous methodologies and ethical standards, fostering collaboration among multidisciplinary teams. Carlson's work not only contributes to the scientific community but also aims to enhance patient quality of life and treatment experiences.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Toronto, Ontario, Canada
Patients applied
Trial Officials
Linda E Carlson, PhD
Principal Investigator
University of Calgary, Cancer Control Alberta, Alberta Health Services
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials